Back to Top

Informing, inspiring, and advancing global innovation to support a healthy, sustainable future

For Immediate Release

International Federation for Adipose Therapeutics and Science (IFATS) Names Stem Cells and Development Its Official Journal

Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com

New Rochelle, NY, April 28, 2021Stem Cells and Development is extremely excited to announce that the International Federation for Adipose Therapeutics and Science (IFATS) has named Stem Cells and Development its Official Journal. IFATS is a non-profit scientific society that promotes the exchange of information among researchers. Their objective is to bring together as members, professionals of the science, medical and industry areas for productive collaborations around the adipose tissue research in all its possible fields. IFATS is currently the world’s only interdisciplinary fat tissue society.

“Stem Cells and Development is globally recognized as the trusted source for critical but fair evaluation of emerging hypotheses and novel findings by basic and clinical scientists seeking the responsible advancement of reparative medicine. The stated areas of interest for the International Federation of Adipose Therapeutics and Science perfectly aligns with Stem Cells and Development: the development of treatments and the use of adipose tissue as a source of mesenchymal stem cells that have the potential to regenerate and repair different body tissues,” states Graham C. Parker, PhD, Editor-in-Chief. “We welcome our evolving relationship with the IFATS leadership, their members’ contributions to the Journal and our shared mission to improve health through a better understanding of biology.”

“IFATS is excited to partner with Stem Cells and Development. This relationship with the Journal will bring tremendous benefits to our members and build awareness for the Journal, which is globally recognized as a premier source of basic, clinical, and translational research on stromal/stem cells of all tissue types and their potential therapeutic applications,” states J. Peter Rubin, MD, FACS, IFATS Board Chair. “Additionally, the IFATS leadership sees this new journal affiliation as an outstanding opportunity to grow the size, scope, and influence of our organization.”
Dr. Parker and the leadership of Stem Cells and Development look forward to working even more closely with the IFATS to enhance their mission, the Journal, and the field.
 
About the Journal
Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. A complete table of contents and free sample issue may be viewed on the Stem Cells and Development website.
 
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com